The negative correlation between Cancer Therapeutics Response Portal (CTRP) drug sensitivity and the expression of HAVCR2 and TIGIT also showed that the higher the expression of LINC00467 was, the less sensitive CTRP drugs were, such as I-BET151, SR-II-138A, and triazolothiadiazine (Figure 5F). The gene discussed is HAVCR2; the disease is cancer.